Lemaitre Vascular (LMAT) Raw Materials (2012 - 2026)

Lemaitre Vascular (LMAT) has 15 years of Raw Materials data on file, last reported at $21.2 million in Q1 2026.

• Raw Materials for Q1 2026 came in at $21.2 million, up 4.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.2 million (up 4.96% YoY), and the FY2025 annual result was $20.9 million, up 9.33% from the prior year.
• Raw Materials climbed to $21.2 million in Q1 2026 per LMAT's latest filing, from $20.9 million in the prior quarter.
• Over five years, Raw Materials peaked at $21.7 million in Q2 2025 and troughed at $12.5 million in Q1 2022.
• A 5-year average of $18.3 million and a median of $19.1 million in 2024 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2022 and 2025: Raw Materials surged 186.37% in 2022, then retreated 3.08% in 2025.
• A 5-year view of Raw Materials shows it stood at $14.9 million in 2022, then gained by 22.8% to $18.3 million in 2023, then rose by 4.23% to $19.1 million in 2024, then climbed by 9.33% to $20.9 million in 2025, then grew by 1.35% to $21.2 million in 2026.
• Business Quant data shows LMAT's Raw Materials at $21.2 million in Q1 2026, $20.9 million in Q4 2025, and $21.0 million in Q3 2025.